TAC Versus TC for Adjuvant Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Docetaxel|DRUG: Doxorubicin|DRUG: Cyclophosphamide
Sponsor: US Oncology Research
Collaborators: Sanofi